Safety evaluation on low-molecular-weight hydroxyethyl starch for volume expansion therapy in pediat

来源 :第4届中国心脏重症大会、2015华夏医学科技论坛——心脏重症论坛、第一届中国·国际重症医学大会 | 被引量 : 0次 | 上传用户:doudouhuijia
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Introduction: The safety of hydroxyethyl starch (HES) forchildrenshould be paid more attention, which has been questioned for adult.The objective of this meta-analysis was to evaluate the safety of HES versusother fluids for volume expansionin pediatric patients.Methods:Randomized controlled trials (RCTs) involving pediatric patients who used 6% low-molecular-weight HES were searched from Pubmed, Embase database and Cochrane Library, published before January 2014.Two reviewers independently extracted the valid data, including the mortality, renal function, coagulationand blood loss,hemodynamic changes, the length of stay (LOS) in hospital and in intensive care unit (ICU).All data were analyzed by I2-test, and the results of statistical analysis were displayed in forest plots.Possible publication bias was tested by funnel plots.Bayesian analysis was performed using Win BUGS with fixed and random effects models developed by Dias.Results:A total of 13 RCTs involving 1,156 pediatric patients were finally included in this meta-analysis.Compared with other fluids, HES did not significantlyincrease mortality(RR=-0.01;95%CI: 0.05 to0.03;P=0.54;I2=6%),Creatinine value (Cr analyzed byI2-test: MD=1.81;95%CI:-0.35 to 3.98;P=0.10;I2=0 %;by Bayesian analysis :Fixed effect model MD=1.77;95%CI:-0.07 to 3.6;Random effects model MD=1.78;95%CI:-1.86 to 5.33),Activated Partial Thromboplastin Time (APTT:MD=0.01;95%CI:-1.05 to1.07;P=0.99;I2=42%) and blood loss (MD=17.72;95%CI:-41.27 to 5.82;P=0.10;I2=0%),but HES significantly decreased blood platelets count(MD=20.99;95%CI:-32.08 to-9.90;P=0.0002;I2=28%)and increased LOS in ICU (MD=0.94;95%CI:0.18to1.70;P=0.02;I2=46%).Conclusions : Compared with other fluids,6% low-molecular-weight HES does not seem to decrease the mortality or Creatinine in pediatric patients, and might have adverse effect on coagulation and increased LOS in ICU.We dont recommend HES as the first resuscitating fluid for pediatric patients.And more high quality RCTs and researches are needed to confirm its safety for children.
其他文献
目的:探索中医药三联疗法对早、中期膝骨性关节炎的临床治疗效果.方法:选择符合标准的早、中期膝关节骨性关节炎110例,随机分成治疗组55例,对照组55例,治疗组采用中医药三联疗
目的:本研究通过检测阳虚质、平和质KOA及阳虚质非KOA患者关节软骨细胞中Ⅱ型胶原α1链(Col2α1)与Sox9的表达水平,初步揭示阳虚体质者易感膝骨性关节炎的内在本质,为中医药调
骨性关节炎(OA)是一种关节退行性病变,迄今为止其发病机制尚不清楚.近年来随着分子生物学的发展,凝血酶成为国内外学者研究OA发病机制的热点,本文就凝血酶在OA的发病机制和治
目的:骨性关节炎(osteoarthritis,OA)病因复杂,与创伤、衰老、遗传等均有联系.最近提出一个新的OA临床亚型,定义为"代谢型OA".该类型OA的发生发展与肥胖、代谢综合征(metaboli
目的:观察关节镜下急性前交叉韧带损伤在小于50%的情况下分别采用保守治疗与单束重建的临床疗效. 方法:自2009年2月至2012年7月,收集急性前交叉韧带部分损伤(小于50%)患者47
股骨颈骨折采用内固定固定后,继发股骨头缺血性坏死的发病率很高,其发生率因各家统计标准不同,差异较大.包义德(Boyd)和塞尔托尔(Salvatore)报告33%、格登(Garden)报告21%、国
本文介绍了踝关节、距下关节的生理构造和生物力学,足部两大功能为承受体重和向前推进,两大性能为稳定性何灵活性:,性能保证因素为多关节和拱形。阐述了脚趾、足弓等部位的解剖
目的:近年来全腔静脉肺动脉连接(Total Cavopulmonary Connection,TCPC)术后的死亡率及并发症发生率逐渐下降,大多数研究均着重于发现TCPC术后远期死亡及并发症发生的危险因素
Background Patients with acute myocardial infarction (AMI) have a high in-hospital mortality rate, even in this era of percutaneous coronary intervention (PCI).
会议
From the Department of Surgical Intensive Care Unit, State Key Laboratory of Cardiovascular Disease,Fuwai Hospital, National Center for Cardiovascular Diseases,
会议